ClinicalTrials.gg
Not yet recruitingNCT07733531SHE RCTUpdated Jul 30, 2026

Self-Compassion, Health, and Empowerment

An interventional study of The Self-Compassion, Health, and Empowerment (SHE) Intervention and Health and Nutrition Program in Intimate Partner Violence (IPV), Depression and/or Anxiety Symptoms and PTSD - Post Traumatic Stress Disorder, sponsored by Yang Li. Not yet recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Yang Li · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
364
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Intimate partner violence (IPV) can have serious and lasting effects on women's mental health and well-being. Chinese immigrant women in the United States often face additional barriers to obtaining IPV and mental health support, including language, cultural, and social challenges. There is a need for culturally appropriate interventions that improve access to care and address the mental health needs of this underserved population.

The purpose of this study is to evaluate the efficacy of the Self-Compassion, Health, and Empowerment (SHE) intervention, a culturally tailored mobile health (mHealth) program designed for Chinese immigrant women experiencing IPV. Participants will be randomly assigned to either the SHE intervention or an attention control program and will complete study assessments over a 12-month follow-up period.

The results of this study will help determine whether the SHE intervention improves mental health and well-being among Chinese immigrant women experiencing IPV and may provide evidence for an accessible, culturally appropriate intervention that can be implemented more broadly.

Read the detailed description

Intimate partner violence (IPV) is a major public health problem that has profound effects on women's physical and mental health. Immigrant women are at increased risk for IPV and often face substantial barriers to accessing support and health services. Chinese immigrants are the largest Asian ethnic group in the United States, yet Chinese immigrant women experiencing IPV remain an underserved population. Cultural stigma, limited English proficiency, immigration-related concerns, social isolation, and limited availability of culturally and linguistically appropriate services contribute to disparities in access to IPV and mental health care.

Mental health problems, including depression, anxiety, and post-traumatic stress disorder (PTSD), are common among women who have experienced IPV. However, few evidence-based interventions have been developed specifically for Chinese immigrant women, and existing services often do not adequately address the cultural and structural barriers that limit access to care.

The Self-Compassion, Health, and Empowerment (SHE) intervention was developed to address these unmet needs. SHE is a culturally tailored, mobile health (mHealth) intervention that combines safety planning and empowerment strategies with self-compassion and relaxation practices to improve psychological well-being. Delivering the intervention remotely through telephone and text messaging is intended to increase accessibility, reduce barriers related to transportation, geography, stigma, and privacy, and facilitate engagement among Chinese immigrant women.

This study is a two-arm randomized controlled trial designed to evaluate the efficacy of the SHE intervention compared with an attention control condition. Participants will be randomly assigned to receive either the SHE intervention or a health education attention control program delivered with the same schedule and frequency of participant contact. The study will evaluate the effects of the intervention on mental health outcomes, including symptoms of depression, anxiety, and PTSD, as well as IPV experiences and other psychosocial outcomes, from baseline through 12 months of follow-up.

The findings from this study will provide evidence regarding the efficacy of a culturally tailored mHealth intervention to improve mental health and well-being among Chinese immigrant women experiencing IPV. If effective, the SHE intervention has the potential to increase access to culturally appropriate support and reduce disparities in mental health care for this underserved population.

02

Conditions studied

  • Intimate Partner Violence (IPV)
  • Depression and/or Anxiety Symptoms
  • PTSD - Post Traumatic Stress Disorder

Keywords

  • Empowerment
  • Self-compassion
  • mindfulness
  • safety
03

In context

Combat Disorders

200 studies on the registry are indexed under Combat Disorders; 90 are open to participants now.

This study's planned enrollment of 364 is above the median of 72 across 167 interventional studies indexed under Combat Disorders.

Browse Combat Disorders studies →

Lead sponsor

Yang Li is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older;
  • Self-identify as a woman;
  • Self-identify as Chinese;
  • Reside in the U.S.;
  • Self-report experiences of any physical, emotional, or sexual violence from an intimate partner within the past year;
  • Self-report symptoms of depression, anxiety, or post-traumatic stress disorder (PTSD).

Exclusion criteria

Exclusion Criteria:

  • Those who cannot speak or understand Mandarin or English;
  • Those with substance use, suicidality, or who have been in mental health care for severe mental illness.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
364 participants (estimated)

Study arms

  • Experimental
    The SHE intervention group

    The intervention will consist of 6 weekly sessions. Session 1 is a phone discussion about an IPV safety brochure covering IPV information, questions from the Danger Assessment, safety planning, options, and available resources. It also includes immigrant-specific content such as immigration-related abuse, legal options for immigrants, and resources for immigrant survivors. Sessions 2-6 will focus on providing mental health self-care resources, with a specific topic assigned each week (Deep Breathing, Progressive Muscle Relaxation, Mindful Self- Compassion, Mindfulness, and Loving-Kindness). Each session includes a video introduction on 1 of our 5 topics, with accompanying audio instructions for exercises. The interventionist will guide participants to review the video at the beginning of each session and encourage them to practice the exercises presented in that session daily for 1 week.

    Behavioral: The Self-Compassion, Health, and Empowerment (SHE) Intervention

  • Active comparator
    The attention control group

    Participants in the attention control group will receive six weekly educational sessions on nutrition and health, matched in delivery mode, timing, and frequency of contacts with the intervention group.

    Behavioral: Health and Nutrition Program

Interventions

  • BehavioralThe Self-Compassion, Health, and Empowerment (SHE) Intervention

    The intervention will consist of 6 weekly sessions. Session 1 is a phone discussion about an IPV safety brochure covering IPV information, questions from the Danger Assessment, safety planning, options, and available resources. It also includes immigrant-specific content such as immigration-related abuse, legal options for immigrants, and resources for immigrant survivors. Sessions 2-6 will focus on providing mental health self-care resources, with a specific topic assigned each week (Deep Breathing, Progressive Muscle Relaxation, Mindful Self- Compassion, Mindfulness, and Loving-Kindness). Each session includes a video introduction on 1 of our 5 topics, with accompanying audio instructions for exercises. The interventionist will guide participants to review the video at the beginning of each session and encourage them to practice the exercises presented in that session daily for 1 week.

  • BehavioralHealth and Nutrition Program

    It consists of six weekly educational sessions focused on nutrition and health. Each week, participants will view a video on a specific nutrition-related topic and complete a quiz/homework (e.g., food label identification, healthy meal planning). Reminder and check-in messages will be sent every other day via text messages to reinforce the content and respond to any participant questions.

06

What researchers measure

Primary outcomes

  1. Depression symptoms

    The instrument used will be the Patient Health Questionnaire-9. The total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.

    Time frame: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups

  2. Anxiety symptoms

    The instrument used will be the Generalized Anxiety Disorder-7. The total scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.

    Time frame: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups

  3. Symptoms of post-traumatic stress disorder (PTSD)

    The instrument used will be the PTSD Checklist for DSM-5. The total scores range from 0 to 80, with higher scores indicating more severe PTSD symptoms.

    Time frame: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups

Secondary outcomes

  1. Intimate partner violence

    The instrument used will be the Revised Conflict Tactics Scales. Item scores within each subscale were summed, with higher scores indicating more frequent experiences of the corresponding behaviors. The scale consists of five subscales: negotiation (6 items; score range = 0-150), psychological aggression (8 items; score range = 0-200), physical assault (12 items; score range = 0-300), sexual coercion (7 items; score range = 0-175), and injury (6 items; score range = 0-150).

    Time frame: Baseline and 6-week, 3-month, 6-month, and 12-month follow-ups

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07733531
Lead sponsor
Yang Li
Responsible party
Yang Li (Assistant Professor, University of Texas at Austin) — Sponsor-investigator
First posted
Jul 29, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Aug 31, 2030 (estimated)
Completion
Aug 31, 2030 (estimated)
Last update
Jul 30, 2026

Study contacts

Yang Li
Contact
yang.li@nursing.utexas.edu
512-471-9075

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion